Mefuparib hydrochloride(CVL218)
Modify Date: 2025-09-12 19:13:08
Mefuparib hydrochloride(CVL218) structure
|
Common Name | Mefuparib hydrochloride(CVL218) | ||
|---|---|---|---|---|
| CAS Number | 1449746-00-2 | Molecular Weight | 334.775 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C17H16ClFN2O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Mefuparib hydrochloride(CVL218)Mefuparib hydrochloride is a potent, highly selective, competitive PARP1/2 inhibitor with IC50 of 3.2/1.9 nM, respectively; displays >406-fold over other major nuclear PARPs including PARP3, TNKS1, TNKS2 and PARP6; reduces poly(ADP-ribose) formation, enhances γH2AX levels, induces G2/M arrest and subsequent apoptosis in homologous recombination repair (HR)-deficient cells; shows potent in vitro and in vivo proliferation and growth inhibition against HR-deficient cancer cells and synergistic sensitization of HR-proficient xenografts to the anticancer drug temozolomide. |
| Name | Mefuparib hydrochloride |
|---|
| Description | Mefuparib hydrochloride is a potent, highly selective, competitive PARP1/2 inhibitor with IC50 of 3.2/1.9 nM, respectively; displays >406-fold over other major nuclear PARPs including PARP3, TNKS1, TNKS2 and PARP6; reduces poly(ADP-ribose) formation, enhances γH2AX levels, induces G2/M arrest and subsequent apoptosis in homologous recombination repair (HR)-deficient cells; shows potent in vitro and in vivo proliferation and growth inhibition against HR-deficient cancer cells and synergistic sensitization of HR-proficient xenografts to the anticancer drug temozolomide. |
|---|---|
| References | References 1. He JX, et al. Oncotarget. 2017 Jan 17;8(3):4156-4168. View Related Products by Target PARP |
| Molecular Formula | C17H16ClFN2O2 |
|---|---|
| Molecular Weight | 334.775 |
| InChIKey | GPFWTAVHQKERKY-UHFFFAOYSA-N |
| SMILES | CNCc1ccc(-c2cc3cc(F)cc(C(N)=O)c3o2)cc1.Cl |